Immune response study of histotripsy in colorectal cancer
Part of Cancer, Digestive system clinical trials.
This trial tests how your body's immune system reacts to a treatment called histotripsy for colorectal cancer that has spread to the liver. Histotripsy uses sound waves to break apart tumors, and the study aims to see if this can help your immune system fight the cancer better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have colorectal cancer that has spread to the liver and is confirmed by a biopsy. The cancer type must be microsatellite stable (MSS).
- You must be scheduled to receive standard histotripsy treatment for your liver tumors.
- Your liver tumors must be visible on a CT or MRI scan done within the last 60 days.
- Your blood counts, kidney, and liver function should be within certain safe limits, as determined by your doctor.
- You must be able to understand and sign a consent form and have an expected survival of at least 90 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects tissue, blood, and imaging samples from people having surgery for colon cancer or related liver tumors, to learn more about the disease and potentially improve future treatments.
This study tests a tiny device that is placed in your liver tumor during surgery. It checks how well different chemotherapy drugs work on your specific cancer, which may help your doctor choose the best treatment for you.
This trial tests whether adding histotripsy—a non-invasive ultrasound treatment that destroys liver tumors—to standard chemotherapy improves outcomes for people with advanced colorectal cancer that has spread to the liver. It may be an option if your cancer is mainly in the liver and you are starting or have recently had chemotherapy.
This study tests a new, noninvasive treatment called histotripsy that uses sound waves to destroy small liver tumors. It is for people whose liver cancer hasn't spread much and who haven't had success with or can't have surgery or other standard treatments.
This trial tests a non-invasive treatment using sound waves (histotripsy) to break up tumors in the abdomen without surgery, aiming to reduce symptoms and improve quality of life. It is designed for people whose tumors cannot be removed surgically.
This trial tests a focused ultrasound therapy called histotripsy to destroy liver tumors that are close to major blood vessels and cannot be surgically removed. The goal is to see if this non-invasive approach is safe and effective for tumors that are otherwise hard to treat.
Hear when a new Colorectal (Colon or Rectal) Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.